• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过结合多种健康信息资源对前瞻性队列研究中的帕金森病病例进行确定。

Parkinson's disease case ascertainment in prospective cohort studies through combining multiple health information resources.

机构信息

University of Utrecht, Institute for Risk Assessment Sciences, Utrecht, The Netherlands.

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.

出版信息

PLoS One. 2020 Jul 1;15(7):e0234845. doi: 10.1371/journal.pone.0234845. eCollection 2020.

DOI:10.1371/journal.pone.0234845
PMID:32609766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7329061/
Abstract

Epidemiological evidence from prospective cohort studies on risk factors of Parkinson's disease (PD) is limited as case ascertainment is challenging due to a lack of registries and the disease course of PD. The objective of this study was to create a case ascertainment method for PD within two prospective Dutch cohorts based on multiple sources of PD information. This method was validated using clinical records from the general practitioners (GPs). Face validity of the case ascertainment was tested for three etiological factors (smoking, sex and family history of PD). In total 54825 participants were included from the cohorts AMIGO and EPIC-NL. Sources of PD information included self-reported PD, self-reported PD medication, a 9 item screening questionnaire (Tanner), electronical medical records, hospital discharge data and mortality records. Based on these sources we developed a likelihood score with 4 categories (no PD, unlikely PD, possible PD, likely PD). For the different sources of PD information and for the likelihood score we present the agreement with GP-validated cases. Risk of PD for established factors was studied by logistic regression as exact diagnose dates were not always available. Based on the algorithm, we assigned 346 participants to the likely PD category. GP validation confirmed 67% of these participants in EPIC-NL, but only 12% in AMIGO. PD was confirmed in only 3% of the participants with a possible PD classification. PD case ascertainment by mortality records (91%), EMR ICPC (82%) and self-reported information (62-69%) had the highest confirmation rates. The Tanner PD screening questionnaire had a lower agreement (18%). Risk estimates for smoking, family history and sex using all likely PD cases were comparable to the literature for EPIC-NL, but not for smoking in AMIGO. Using multiple sources of PD evidence in cohorts remains important but challenging as performance of sources varied in validity.

摘要

前瞻性队列研究对帕金森病(PD)危险因素的流行病学证据有限,因为缺乏登记处和 PD 疾病的过程,因此病例确定具有挑战性。本研究的目的是基于 PD 的多个信息来源,在两个前瞻性荷兰队列中创建 PD 的病例确定方法。该方法使用来自全科医生(GP)的临床记录进行了验证。使用三个病因因素(吸烟,性别和 PD 家族史)对病例确定的表面有效性进行了测试。总共从 AMIGO 和 EPIC-NL 队列中纳入了 54825 名参与者。PD 信息来源包括自我报告的 PD,自我报告的 PD 药物,9 项筛查问卷(Tanner),电子病历,住院数据和死亡率记录。基于这些来源,我们开发了一个具有 4 个类别的可能性评分(无 PD,不太可能 PD,可能 PD,很可能 PD)。对于不同的 PD 信息来源和可能性评分,我们均展示了与 GP 验证病例的一致性。由于并非总是可以获得确切的诊断日期,因此通过逻辑回归研究了 PD 的风险因素。基于该算法,我们将 346 名参与者分配到可能 PD 类别。在 EPIC-NL 中,GP 验证证实了其中 67%的参与者,而在 AMIGO 中仅证实了 12%的参与者。在可能 PD 分类的参与者中,仅确认了 3%的 PD。死亡率记录(91%),EMR ICPC(82%)和自我报告信息(62-69%)的 PD 病例确定具有最高的确认率。Tanner PD 筛查问卷的一致性较低(18%)。使用所有可能 PD 病例进行的吸烟,家族史和性别的风险估计值与 EPIC-NL 的文献值相当,但在 AMIGO 中,吸烟则不然。在队列中使用 PD 的多个信息来源仍然很重要,但具有挑战性,因为来源的有效性各不相同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4e/7329061/9caa9bb47b03/pone.0234845.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4e/7329061/9f98eae38fdc/pone.0234845.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4e/7329061/e94886b3631c/pone.0234845.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4e/7329061/9caa9bb47b03/pone.0234845.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4e/7329061/9f98eae38fdc/pone.0234845.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4e/7329061/e94886b3631c/pone.0234845.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4e/7329061/9caa9bb47b03/pone.0234845.g003.jpg

相似文献

1
Parkinson's disease case ascertainment in prospective cohort studies through combining multiple health information resources.通过结合多种健康信息资源对前瞻性队列研究中的帕金森病病例进行确定。
PLoS One. 2020 Jul 1;15(7):e0234845. doi: 10.1371/journal.pone.0234845. eCollection 2020.
2
Parkinson's disease case ascertainment in a large prospective cohort.在一个大型前瞻性队列中对帕金森病病例进行确定。
PLoS One. 2021 May 19;16(5):e0251852. doi: 10.1371/journal.pone.0251852. eCollection 2021.
3
Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study.在一项基于人群的队列研究中利用医疗保险理赔数据加强帕金森病的病例确诊:心血管健康研究
Pharmacoepidemiol Drug Saf. 2014 Feb;23(2):119-27. doi: 10.1002/pds.3552. Epub 2013 Dec 13.
4
Parkinson's Disease Case Ascertainment in the Sister Study: A Cohort for Environmental Health Research.帕金森病病例在姐妹研究中的确定:一个环境健康研究队列。
J Parkinsons Dis. 2023;13(5):729-742. doi: 10.3233/JPD-230053.
5
Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study.EPIC队列中帕金森病的病例确诊:NeuroEPIC4PD研究
Neurodegener Dis. 2015;15(6):331-8. doi: 10.1159/000381857. Epub 2015 Sep 17.
6
Prospective association between emotional health and clinical evidence of Parkinson's disease.情绪健康与帕金森病临床证据之间的前瞻性关联。
Eur J Neurol. 2008 Nov;15(11):1148-54. doi: 10.1111/j.1468-1331.2008.02299.x. Epub 2008 Sep 13.
7
Cross-cultural validation of the Cebuano version of a screening questionnaire for Parkinson's disease.菲律宾宿务语版帕金森病筛查问卷的跨文化验证。
Arq Neuropsiquiatr. 2022 Dec;80(12):1239-1245. doi: 10.1055/s-0042-1758652. Epub 2022 Dec 29.
8
The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort.英国老年人帕金森病自我报告诊断的频率与有效性:医学研究委员会认知功能与衰老研究队列研究
BMC Neurol. 2006 Aug 22;6:29. doi: 10.1186/1471-2377-6-29.
9
Validation of secondary data sources to identify Parkinson disease against clinical diagnostic criteria.利用二级数据源验证帕金森病与临床诊断标准的符合度。
Am J Epidemiol. 2015 Feb 1;181(3):185-90. doi: 10.1093/aje/kwu326. Epub 2014 Dec 29.
10
Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person.仅在线的帕金森病研究队列与面对面评估的队列比较。
J Parkinsons Dis. 2020;10(2):677-691. doi: 10.3233/JPD-191808.

引用本文的文献

1
Traffic-related air pollution, road traffic noise, and Parkinson's disease: Evaluations in two Dutch cohort studies.交通相关空气污染、道路交通噪音与帕金森病:两项荷兰队列研究的评估
Environ Epidemiol. 2023 Oct 19;7(6):e272. doi: 10.1097/EE9.0000000000000272. eCollection 2023 Dec.
2
Validation of self-reported cardiovascular problems in childhood cancer survivors by contacting general practitioners: feasibility and results.通过联系全科医生验证儿童癌症幸存者自述的心血管问题:可行性和结果。
BMC Prim Care. 2024 Mar 8;25(1):81. doi: 10.1186/s12875-024-02322-7.
3
Animal Approaches to Studying Risk Factors for Parkinson's Disease: A Narrative Review.

本文引用的文献

1
Epidemiology of Parkinson's disease.帕金森病的流行病学
J Neural Transm (Vienna). 2017 Aug;124(8):901-905. doi: 10.1007/s00702-017-1686-y. Epub 2017 Feb 1.
2
Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study.EPIC队列中帕金森病的病例确诊:NeuroEPIC4PD研究
Neurodegener Dis. 2015;15(6):331-8. doi: 10.1159/000381857. Epub 2015 Sep 17.
3
Occupational exposures and Parkinson's disease mortality in a prospective Dutch cohort.荷兰一项前瞻性队列研究中的职业暴露与帕金森病死亡率
研究帕金森病风险因素的动物实验方法:一篇叙述性综述
Brain Sci. 2024 Feb 2;14(2):156. doi: 10.3390/brainsci14020156.
4
Parkinson's Disease Case Ascertainment in the Sister Study: A Cohort for Environmental Health Research.帕金森病病例在姐妹研究中的确定:一个环境健康研究队列。
J Parkinsons Dis. 2023;13(5):729-742. doi: 10.3233/JPD-230053.
5
Incidence of Parkinson's disease in French women from the E3N cohort study over 27 years of follow-up.27 年随访期间 E3N 队列研究中法国女性帕金森病的发病率。
Eur J Epidemiol. 2022 May;37(5):513-523. doi: 10.1007/s10654-022-00851-y. Epub 2022 Mar 14.
6
Parkinson's disease case ascertainment in a large prospective cohort.在一个大型前瞻性队列中对帕金森病病例进行确定。
PLoS One. 2021 May 19;16(5):e0251852. doi: 10.1371/journal.pone.0251852. eCollection 2021.
Occup Environ Med. 2015 Jun;72(6):448-55. doi: 10.1136/oemed-2014-102209. Epub 2015 Feb 23.
4
Validation of secondary data sources to identify Parkinson disease against clinical diagnostic criteria.利用二级数据源验证帕金森病与临床诊断标准的符合度。
Am J Epidemiol. 2015 Feb 1;181(3):185-90. doi: 10.1093/aje/kwu326. Epub 2014 Dec 29.
5
The population-based Occupational and Environmental Health Prospective Cohort Study (AMIGO) in The Netherlands.荷兰基于人群的职业与环境卫生前瞻性队列研究(AMIGO)。
BMJ Open. 2014 Nov 26;4(11):e005858. doi: 10.1136/bmjopen-2014-005858.
6
Mortality and cancer incidence in the EPIC-NL cohort: impact of the healthy volunteer effect.EPIC-NL队列中的死亡率和癌症发病率:健康志愿者效应的影响。
Eur J Public Health. 2015 Feb;25(1):144-9. doi: 10.1093/eurpub/cku045. Epub 2014 Apr 15.
7
Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study.在一项基于人群的队列研究中利用医疗保险理赔数据加强帕金森病的病例确诊:心血管健康研究
Pharmacoepidemiol Drug Saf. 2014 Feb;23(2):119-27. doi: 10.1002/pds.3552. Epub 2013 Dec 13.
8
Meta-analysis of early nonmotor features and risk factors for Parkinson disease.帕金森病早期非运动特征及危险因素的荟萃分析。
Ann Neurol. 2012 Dec;72(6):893-901. doi: 10.1002/ana.23687. Epub 2012 Oct 15.
9
Screening questionnaires for parkinsonism: a systematic review.帕金森病筛查问卷:系统评价。
Parkinsonism Relat Disord. 2012 Mar;18(3):216-24. doi: 10.1016/j.parkreldis.2011.09.003. Epub 2011 Sep 17.
10
Milestones in Parkinson's disease therapeutics.帕金森病治疗的里程碑。
Mov Disord. 2011 May;26(6):1072-82. doi: 10.1002/mds.23714.